AMS shares jump 16.31% after chairman buys $1.34 million stock
American Shared Hospital Services shares rose 16.31% in pre-market trading to $1.64 on Thursday after Executive Chairman Raymond C. Stachowiak purchased 586,468 shares at $2.28 per share. The $1.34 million private transaction was disclosed in an SEC filing. The stock, which has fallen 41.25% over the past year, is trading near its 52-week low of $1.26.

*this image is generated using AI for illustrative purposes only.
American Shared Hospital Services shares rose 16.31% in pre-market trading to $1.64 on Thursday, driven by a significant insider purchase disclosed in a Securities and Exchange Commission filing. The transaction signals confidence from leadership despite the stock's recent performance near its annual lows.
Insider Transaction Details
Executive Chairman Raymond C. Stachowiak acquired 586,468 shares of the California-based healthcare company at $2.28 per share in a private transaction on Monday. The purchase, valued at approximately $1.34 million, was executed through his entity, RCS/TIG Holdings LLC.
Following the transaction, Stachowiak's beneficial ownership increased. He holds 752,500 shares through RCS Investments, Inc. and 760,559 shares through Stachowiak Equity Fund LLC, among other investment vehicles.
Trading Metrics and Performance
The market reaction follows a period of heightened volatility and declining value for the stock. American Shared has a market capitalization of $9.34 million. Over the past 12 months, the stock has dropped 41.25%.
| Metric | Value |
|---|---|
| 52-Week High | $3.11 |
| 52-Week Low | $1.26 |
| Short Interest | 3.60% |
| Relative Strength Index (RSI) | 46.63 |
Trading volume spiked significantly on Wednesday, reaching 2.05 million shares. This figure represents approximately 14.5 times the stock’s average daily volume of 141,390 shares, indicating exceptionally strong trading activity prior to the insider disclosure. The small-cap stock is currently trading close to its annual low, with technical indicators pointing to a negative price trend across all time frames.
Will the insider purchase trigger additional institutional investment or sustained retail interest?
What specific operational strategies does management plan to implement to reverse the 41.25% annual decline?
How will the company address the negative price trend indicated by technical indicators across all time frames?
























